Canada Pension Plan Investment Board raised its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 59.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 40,400 shares of the company's stock after acquiring an additional 15,100 shares during the period. Canada Pension Plan Investment Board's holdings in Option Care Health were worth $937,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of OPCH. Cornerstone Investment Partners LLC grew its position in Option Care Health by 3.6% during the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after purchasing an additional 333 shares during the last quarter. UMB Bank n.a. grew its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after buying an additional 346 shares during the last quarter. Assetmark Inc. increased its position in shares of Option Care Health by 2.0% during the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock valued at $579,000 after acquiring an additional 487 shares in the last quarter. Pacer Advisors Inc. increased its position in shares of Option Care Health by 2.2% during the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock valued at $591,000 after acquiring an additional 537 shares in the last quarter. Finally, Sheets Smith Wealth Management raised its holdings in Option Care Health by 2.4% in the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock worth $553,000 after acquiring an additional 550 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.
Insider Transactions at Option Care Health
In related news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.64% of the company's stock.
Analysts Set New Price Targets
OPCH has been the subject of a number of research analyst reports. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a report on Monday, April 21st. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $33.75.
View Our Latest Research Report on OPCH
Option Care Health Stock Performance
Shares of NASDAQ:OPCH traded down $1.67 during midday trading on Tuesday, hitting $31.31. The company had a trading volume of 3,551,375 shares, compared to its average volume of 1,788,339. The company has a fifty day moving average of $33.37 and a two-hundred day moving average of $28.78. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a market cap of $5.14 billion, a price-to-earnings ratio of 26.17, a PEG ratio of 2.30 and a beta of 1.07.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.